Charming Medical LTD

F-113D

Schedule 13D - Activist Investments

NASDAQ
Charming Medical Ltd's CEO, Kit Wong, has filed a Schedule 13D, revealing beneficial ownership of 91.65% of the company's aggregate voting power.